Crystalline sirolimus-coated balloon (cSCB) angioplasty in an all-comers, patient population with stable and unstable coronary artery disease including chronic total occlusions: rationale, methodology and design of the SCORE trial.
Otto S, Díaz V, Weilenmann D, Cuculi F, Nuruddin A, Leibundgut G, Alfonso F, Wan Ahmad W, Pyxaras S, Rittger H, Steen P, Gaede L, Schulze C, Wöhrle J, Rosenberg M, Waliszewski M. Crystalline sirolimus-coated balloon (cSCB) angioplasty in an all-comers, patient population with stable and unstable coronary artery disease including chronic total occlusions: rationale, methodology and design of the SCORE trial. BMC Cardiovasc Disord 2023; 23:176.
31.03.2023
Crystalline sirolimus-coated balloon (cSCB) angioplasty in an all-comers, patient population with stable and unstable coronary artery disease including chronic total occlusions: rationale, methodology and design of the SCORE trial.
31.03.2023
BMC Cardiovasc Disord 2023; 23:176
Otto Sylvia, Díaz Victor Alfonso Jiménez, Weilenmann Daniel, Cuculi Florim, Nuruddin Amin Ariff, Leibundgut Gregor, Alfonso Fernando, Wan Ahmad Wan Azman, Pyxaras Stylianos, Rittger Harald, Steen Philip, Gaede Luise, Schulze Christian, Wöhrle Jochen, Rosenberg Mark, Waliszewski Matthias W
Weiter
